Klára Tótpál
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Immunology 32
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 6
-
- Cell death mechanisms and regulation 16
- RNA Interference and Gene Delivery 10
- Co-authors
- Avi Ashkenazi (11 shared papers)David A. Lawrence (7 shared papers)S.G. Hymowitz (6 shared papers)Mark Ultsch (3 shared papers)Laura DeForge (4 shared papers)Bharat B. Aggarwal (8 shared papers)Leonard G. Presta (2 shared papers)Michael G. Mulkerrin (2 shared papers)
- Journals
- Cancer Research (5 papers)FEBS Letters (5 papers)The Journal of Immunology (3 papers)Journal of Biological Chemistry (3 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- United StatesFranceHungary
In The Last Decade
Klára Tótpál
56 papers receiving 5.1k citations
Klára Tótpál's Hit Papers
Peers
Comparison fields: 5 of 104
- Immunology 2.1k
- Radiology, Nuclear Medicine and Imaging 1.5k
- Oncology 1.7k
- Molecular Biology 3.5k
- Cancer Research 642
Countries citing papers authored by Klára Tótpál
This map shows the geographic impact of Klára Tótpál's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klára Tótpál with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klára Tótpál more than expected).
Fields of papers citing papers by Klára Tótpál
This network shows the impact of papers produced by Klára Tótpál. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klára Tótpál. The network helps show where Klára Tótpál may publish in the future.
Co-authors
The 25 scholars most cited alongside Klára Tótpál, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 487 | |
| 2 | 2002 | 431 | |
| 3 | 2001 | 401 | |
| 4 | 2001 | 371 | |
| 5 | 2000 | 336 | |
| 6 | PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer Hit paper breakdown → | 2020 | 316 |
| 7 | 2017 | 270 | |
| 8 | 2004 | 234 | |
| 9 | 2000 | 223 | |
| 10 | 2001 | 220 | |
| 11 | 2011 | 213 | |
| 12 | 2009 | 197 | |
| 13 | 2010 | 179 | |
| 14 | 2019 | 128 | |
| 15 | 1995 | 122 | |
| 16 | 2008 | 120 | |
| 17 | 2018 | 112 | |
| 18 | 2004 | 97 | |
| 19 | 2018 | 93 | |
| 20 | 1990 | 92 |
About Klára Tótpál
Klára Tótpál is a scholar working on Immunology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 59 papers that have together received 5.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (20 papers), Cell death mechanisms and regulation (16 papers), CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (10 papers), RNA Interference and Gene Delivery (10 papers), Immune Cell Function and Interaction (6 papers), HER2/EGFR in Cancer Research (5 papers) and NF-κB Signaling Pathways (5 papers). The work is most often cited by research in Immunology (2.1k citations), Radiology, Nuclear Medicine and Imaging (1.5k citations), Oncology (1.7k citations), Molecular Biology (3.5k citations) and Cancer Research (642 citations). Klára Tótpál has collaborated with scholars based in United States, France and Hungary. Frequent co-authors include Avi Ashkenazi, David A. Lawrence, S.G. Hymowitz, Mark Ultsch, Laura DeForge, Bharat B. Aggarwal, Leonard G. Presta, Michael G. Mulkerrin, Pin Yee Wong and Hélène Gazzano-Santoro. Their work appears in journals such as Cancer Research, FEBS Letters, The Journal of Immunology, Journal of Biological Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.